Search Result
24 search results for Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma, NCCN clinical practice guidelines in oncology – Pancreatic Adenocarcinoma
https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdfNCCN Guidelines Pancreatic Adenocarcinoma
NCCN Guidelines Pancreatic Adenocarcinoma, NCCN clinical practice guidelines in oncology – Pancreatic Adenocarcinoma
https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdfPermission to Cite or Use NCCN Content
Peritoneal Cancer Palliative Care Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic, Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia, Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia Pediatric Aggressive Mature B-Cell, Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric, Cancer Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia Pediatric Aggressive Mature B
https://www.nccn.org/guidelines/permission-to-cite-or-use-nccn-contentResume Screening
/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric Acute, Copies Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Ampullary Adenocarcinoma Anal, Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma Squamous Cell Skin, Screening Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Genetic, Gastrointestinal Stromal Tumors (GIST) Genetic Testing for Hereditary Breast, Ovarian, Pancreatic
https://www.nccn.org/covid-19/resume-screeningTransparency Process
Version: 2.2025 ( Small Bowel Adenocarcinoma ) Date: 2025-01-14 Transparency Panel, Adenocarcinoma ) Date: 2024-08-29 Transparency Panel Disclosures/Attendance, Adenocarcinoma ) Date: 2024-06-21 Transparency Panel Disclosures/Attendance, /Attendance Version: 3.2024 ( Small Bowel Adenocarcinoma ) Date: 2024-04-17 Transparency, Adenocarcinoma ) Date: 2024-02-09 Transparency Panel Disclosures/Attendance Version
https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendationsGuidelines Panels
Panel Pancreatic Adenocarcinoma Panel, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel
https://www.nccn.org/guidelines/guidelines-panels-and-disclosure/disclosure-panelsNCCN-2025-Annual-Conference-Exhibit-Guide
• Gastrointestinal Stromal Tumors (GIST) • Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, -Small Cell Lung Cancer: Metastatic • Ovarian Cancer • Palliative Care • Pancreatic Cancer, Bowel Adenocarcinoma • Small Cell Lung Cancer • Soft Tissue Sarcoma • Squamous Cell Skin Cancer
https://www.nccn.org/docs/default-source/education-research/nccn-2025-annual-conference-exhibit-guide.pdf?sfvrsn=5765e4e8_2Current Opportunities
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric, Adenocarcinoma Anal Carcinoma Basal Cell Skin Cancer B-Cell Lymphomas Biliary Tract Cancers Bladder, Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma, Cancer Screening Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, , Pancreatic, and Prostate Cancers Graft-Versus-Host Disease Hodgkin Lymphoma Hodgkin Lymphoma
https://www.nccn.org/education-research/nccn-oncology-research-program/current-opportunitiesTreatment by Cancer Type
Version: 3.2024 Pancreatic Adenocarcinoma, Version: 2.2025 Ampullary Adenocarcinoma, Small Bowel Adenocarcinoma Version: 2.2025
https://www.nccn.org/guidelines/category_1Submission Request Form
Pancreatic Adenocarcinoma - 1.2025 Pediatric Acute Lymphoblastic Leukemia - 2.2025 Pediatric, ) Oncology - 2.2025 Adult Cancer Pain - 3.2024 Ampullary Adenocarcinoma - 2.2025 Anal Carcinoma, : Breast, Ovarian, Pancreatic, and Prostate - 2.2025 Genetic/Familial High-Risk Assessment: Colorectal, Detection - 2.2024 Rectal Cancer - 5.2024 Small Bowel Adenocarcinoma - 2.2025 Small Cell Lung
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-formHIT
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma, Adenocarcinoma Anal Carcinoma Basal Cell Skin Cancer B-Cell Lymphomas Biliary Tract Cancers, Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma, Colorectal Cancer Screening Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, , Ovarian, Pancreatic, and Prostate Cancers Graft-Versus-Host Disease Hodgkin Lymphoma Hodgkin
https://www.nccn.org/redirects/hitGuidelines for Patients
Pancreatic Cancer Version: 2023 Peripheral T, Bowel Adenocarcinoma Version: 2024 Small, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patientsGuidelines for Patients
Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers, Version: 2023 Pancreatic Cancer, Version: 2024 Small Bowel Adenocarcinoma
https://www.nccn.org/guidelines/patientsHarmonized Guidelines
Version 2.2023 Pancreatic Adenocarcinoma Version 2.2022 Pediatric Acute
https://www.nccn.org/global/what-we-do/harmonized-guidelinesTreatment by Cancer Type
Cancer Version: 2024 Pancreatic Cancer, Version: 2024 Small Bowel Adenocarcinoma, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/treatment-by-cancer-typeDetection, Prevention, and Risk Reduction
Cancer Version: 2024 Pancreatic Cancer, Version: 2024 Small Bowel Adenocarcinoma, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/detection-prevention-and-risk-reductionSupportive Care
Cancer Version: 2024 Pancreatic Cancer, Version: 2024 Small Bowel Adenocarcinoma, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/supportive-careSpecific Populations
Cancer Version: 2024 Pancreatic Cancer, Version: 2024 Small Bowel Adenocarcinoma, Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancers
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/specific-populationsORP Grant History
with Advanced Pancreatic Cancer Renuka Iyer, MD Roswell Park Comprehensive Cancer Center Multicenter, Open Label, Phase II Clinical Study of Gemcitabine, Capecitabine and Avastin in Pancreatic Cancer, Gemcitabine plus Capecitabine in Patients with Advanced Pancreatic and Biliary Carcinomas Daniel Laheru, ) Genotype-Directed Phase II Trial of Oral Capecitabine for 2nd Line Treatment of Advanced Pancreatic Cancer, Adenocarcinoma Lakshmi Pendyala, PhD Roswell Park Comprehensive Cancer Center Gene Expression
https://www.nccn.org/education-research/nccn-oncology-research-program/orp-grant-historyGuidelines With Evidence Blocks
Pancreatic Adenocarcinoma Version 3.2024 Pediatric Acute Lymphoblastic Leukemia, Leukemia Version 2.2024 Acute Myeloid Leukemia Version 3.2024 Ampullary Adenocarcinoma, Adenocarcinoma Version 1.2025 Small Cell Lung Cancer Version 3.2025 Soft Tissue Sarcoma
https://www.nccn.org/guidelines/guidelines-with-evidence-blocks